Towards a definition of "difference" in osteoarthritis

Journal of Rheumatology

Volumn 28, Issue 2, 2001, Pages 427-430

  Bellamy, N ^a   Carr, A ^a   Dougados, M ^a   Shea, B ^a   Wells, G ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Discrimination; Minimally clinically important difference; Osteoarthritis

Indexed keywords

CONFERENCE PAPER; DISCRIMINANT ANALYSIS; DISEASE COURSE; HUMAN; OSTEOARTHRITIS; OUTCOMES RESEARCH; PATIENT SATISFACTION; PRIORITY JOURNAL;

CLINICAL TRIALS; DATABASES, BIBLIOGRAPHIC; DISABILITY EVALUATION; HUMANS; OSTEOARTHRITIS; PATIENT SATISFACTION; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 0035117874     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Dr. Douglas Taylor and half a century of musculoskeletal Kelvinism
2. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip and hand osteoarthritis. Consensus development at OMERACT III
3. Osteoarthritis Research Society (OARS) Task Force Report: Design and conduct of clinical trials in patients with osteoarthritis; recommendations from a task force of the Osteoarthritis Research Society
4. WOMAC user guide IV
5. Looking for important change/difference in studies of responsiveness
6. Indexes of severity for osteoarthritis of the hip and knee. Validation - Value of comparison with other assessment tests
7. Development of the Australian/Canadian (AUSCAN) Osteoarthritis Hand Index
8. Validation of an algofunctional index for osteoarthritis of the hand
9. Rhythmic variations in pain perception in osteoarthritis of the knee
10. Circadian rhythm in pain, stiffness and manual dexterity in osteoarthritis of the hand: Relationship between discomfort and disability
11. Minimum perceptible clinical improvement in osteoarthritis: The WOMAC Questionnaire and Global Assessments [abstract]
12. Osteoarthritis antirheumatic drug trials. I. Effects of standardisation procedures on observer dependent outcome measures
13. Osteoarthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials
14. Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials - Results of a consensus development (delphi exercise)
15. Response criteria for clinical trials on osteoarthritis of the knee and hip
16. Patient education and the consultation: The importance of lay beliefs
17. Physician-patient agreement on patients' priorities for important treatment outcomes
18. Quality of life in chronic diseases: Perceptions of elderly patients
19. Rheumatoid arthritis patients' expectations for treatment outcomes
20. Expectations of treatment and outcome in patients awaiting joint replacement surgery and general orthopaedic outpatients [abstract]
21. Patients' self-assessment of disease activity and severity in rheumatoid arthritis
22. What influences placebo response to a complementary therapy, glucosamine sulfate?
23. Requirement for total hip arthroplasty: An outcome measure of hip osteoarthritis